Navigation Links
Microfluidic Systems (MFSI) is Awarded Four New Patents in the Field of Automated Biological Sample Processing and Detection.
Date:9/23/2010

ver 25 years, including the world's first miniaturized, portable, battery-operated, real-time, polymerase-chain-reaction (PCR)-based detection system. For more information, please contact MFSI at 510-354-0400 or visit the website, www.microfluidicsystems.com. M. Allen Northrup Ph.D.CEO and Chief Technology OfficerMicroFluidic Systems47790 Westinghouse DrFremont, CA 94539510-354-0400 ext 201510-354-0404 (fax)northrup@microfluidicsystems.comwww.microfluidicsystems.com
'/>"/>
SOURCE Microfluidic Systems
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. LOREAL and Hurel Corporation Announce R&D Collaboration to Develop a Non-Animal Alternative, Microfluidic Biochip
2. Microfluidics Enters into Exclusive Partnership with ATS Scientific to Expand Distribution in Canada
3. Microfluidics International Corporation to Report Fourth Quarter and Year-end 2009 Financial Results on February 23, 2010
4. Microfluidics International Corporation Announces Fourth Quarter and Year-End 2009 Financial Results
5. Microfluidics Announces Two New Board Members
6. Biocept, Inc. Announces Issuance of Patent for its Microfluidic Technology
7. Microfluidics International Corporation to Report Second Quarter 2010 Financial Results on August 10, 2010
8. Life Recovery Systems Receives European CE Mark Approval for Its ThermoSuit(R) System
9. Flexible Medical Systems Raises $1.2M Seed Investment for Initial Human Trials
10. Boston Scientific to Release Broad Range of Clinical Trial Data Reinforcing Safety and Efficacy of Taxus(R) Coronary Stent Systems at TCT 2007
11. BD and PEPFAR Collaborate to Strengthen Laboratory Systems in Fight Against HIV/AIDS and TB
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/17/2015)... 2015   IBA Molecular, a global leader ... that it has signed a definitive agreement to sell ... NA), to Illinois Health and Science (IHS). Under IHS ownership, ... company headquartered in Dulles, Virginia , ... new product and footprint synergies. IBA Molecular is jointly ...
(Date:4/17/2015)... , April 17, 2015 Bionomics Limited (ASX:BNO, ... development of innovative therapeutics for the treatment of cancer ... the presentation of data from three of its most ... Cancer Research (AACR) 106 th Annual Meeting being ... PA USA. The presentation ...
(Date:4/16/2015)... WASHINGTON , April 16, 2015 A drug ... the eyesight of people with multiple sclerosis (MS), according to ... American Academy of Neurology,s 67th Annual Meeting in ... "About half of people with MS experience at ... neuritis, in which the nerve carrying vision from the eye ...
Breaking Medicine Technology:Health Care System to Acquire IBA Molecular North America 2Health Care System to Acquire IBA Molecular North America 3Bionomics Showcases Oncology Drug Development Programs at 2015 AACR Annual Meeting 2Bionomics Showcases Oncology Drug Development Programs at 2015 AACR Annual Meeting 3Bionomics Showcases Oncology Drug Development Programs at 2015 AACR Annual Meeting 4Bionomics Showcases Oncology Drug Development Programs at 2015 AACR Annual Meeting 5Epilepsy Drug May Preserve Eyesight for People with MS 2
... Cephalon, Inc. (Nasdaq: CEPH ) today reported 2010 ... to net sales of $2.152 billion for 2009.  Basic income ... expense and certain other items, adjusted net income for full ... the previous year.  This exceeded the company,s adjusted net income ...
... are reporting problems receiving medically required home medical equipment ... Medicare,s "competitive" bidding program in Cleveland and Cincinnati. The ... and people living with disabilities in Cleveland and Cincinnati ... program began in nine areas on January 1 and ...
Cached Medicine Technology:Cephalon Reported Record Sales, Adjusted Net Income and Cash From Operations in 2010 2Cephalon Reported Record Sales, Adjusted Net Income and Cash From Operations in 2010 3Cephalon Reported Record Sales, Adjusted Net Income and Cash From Operations in 2010 4Cephalon Reported Record Sales, Adjusted Net Income and Cash From Operations in 2010 5Cephalon Reported Record Sales, Adjusted Net Income and Cash From Operations in 2010 6Cephalon Reported Record Sales, Adjusted Net Income and Cash From Operations in 2010 7Cephalon Reported Record Sales, Adjusted Net Income and Cash From Operations in 2010 8Cephalon Reported Record Sales, Adjusted Net Income and Cash From Operations in 2010 9Cephalon Reported Record Sales, Adjusted Net Income and Cash From Operations in 2010 10Cephalon Reported Record Sales, Adjusted Net Income and Cash From Operations in 2010 11Cephalon Reported Record Sales, Adjusted Net Income and Cash From Operations in 2010 12Cephalon Reported Record Sales, Adjusted Net Income and Cash From Operations in 2010 13Cephalon Reported Record Sales, Adjusted Net Income and Cash From Operations in 2010 14Cephalon Reported Record Sales, Adjusted Net Income and Cash From Operations in 2010 15Seniors in Ohio Report Problems With Access to Home Medical Equipment and Services Under Controversial Medicare Bidding System 2Seniors in Ohio Report Problems With Access to Home Medical Equipment and Services Under Controversial Medicare Bidding System 3
(Date:4/18/2015)... 19, 2015 For some people, tattoos are ... for the rest of their lives, as they have spent ... put in a great amount of thought on their designs. ... have outgrown them or simply want them removed for personal ... their tattoo, and in 2012-13 there was a 43 percent ...
(Date:4/18/2015)... Carinsurancesavings.biz has released a new blog post explaining ... Spring. , Spring can be a great season ... sure they compare the newest policies before deciding on ... about Spring car insurance offers by reading the newly ... becoming more and more popular. Many insurance brokerage websites ...
(Date:4/18/2015)... NEW YORK (PRWEB) April 18, 2015 ... (AMO) are hosting a ‘Strategies for Success’ program for ... Refractive Surgeons meeting in San Diego, where eye surgeon ... Moderator’ for this invitation-only event. Dr. Martin is the ... and Review of Ophthalmology chose Dr. Martin to lead ...
(Date:4/18/2015)... 2015 Patients who undergo radiation for ... later in life, but the disease is likely to ... unrelated to radiation. Surviving Mesothelioma has just posted the ... Click here to read it now. , Scientists ... of 45 patients who had both a hematologic cancer ...
(Date:4/18/2015)... April 18, 2015 On April 14th, 2015, ... Report , which they say, “exposes a tactical shift by ... malware variants were introduced in 2014 - almost a million ... Day threats to be identified and patched by prominent manufacturers ... clear that doing business in a digital world can be ...
Breaking Medicine News(10 mins):Health News:Dennis Dass, M.D. is Shattering the Past While Revealing the Future 2Health News:Auto Insurance Plans Are Cheaper During Spring! 2Health News:Dr. Jeffrey Martin Invited to Share Latest Breakthroughs in Cataract Care During Roundtable Discussion at National 2015 ASCRS Meeting In San Diego 2Health News:New Study Examines Relationship Between Radiation for Hematologic Cancers and Development of Mesothelioma, According to Surviving Mesothelioma 2Health News:Cyber Attackers Continue to Fine Tune Deception and Stealth Tactics According to New Report 2Health News:Cyber Attackers Continue to Fine Tune Deception and Stealth Tactics According to New Report 3Health News:Cyber Attackers Continue to Fine Tune Deception and Stealth Tactics According to New Report 4Health News:Cyber Attackers Continue to Fine Tune Deception and Stealth Tactics According to New Report 5
... 10, 2007 The sleep patterns of patients in ... barely spend any time in the restorative stages of ... physicians have found. , Current clinical-care protocols routinely and ... time when the need for adequate rest is perhaps ...
... Overall Survival Advantage in Elderly Myeloma ... Added to Standard Therapy - Data Presented at ... Dec. 9 Pharmion Corporation (Nasdaq:,PHRM) today announced final ... that the addition of,Thalidomide to standard treatment improves survival ...
... - Two drugs approved for use as second line therapy ... therapy for newly diagnosed patients in two clinical trials, research ... D. Anderson Cancer Center report at the 49th annual meeting ... patients in both trials have a complete cytogenetic response - ...
... Health & Science University Cancer Institute researchers have opened a ... , We are looking under the surface of CML to ... have discovered abnormal cells in the early stem cell population ... clone. These are abnormal cells that are not part of ...
... off going to the doctor or overindulge in unhealthy ... -- The holiday season is also the season for ... of the Vanderbilt Heart and Vascular Institute at Vanderbilt ... Churchwell, a look at a U.S. database of 53 ...
... GA, December 8, 2007 -- Results from two investigational ... bortezomib provide preliminary anti-tumor activity in patients with relapsed ... showed that 10 of 21 (48 percent) evaluable patients ... and bortezomib combination treatment. Data from a second ...
Cached Medicine News:Health News:Physicians seek to improve the quality of sleep in ICU, researchers at UT Southwestern report 2Health News:Thalidomide Added to Standard Therapy Prolongs Overall Survival in Newly Diagnosed Multiple Myeloma Patients Over Age 75 2Health News:Thalidomide Added to Standard Therapy Prolongs Overall Survival in Newly Diagnosed Multiple Myeloma Patients Over Age 75 3Health News:Thalidomide Added to Standard Therapy Prolongs Overall Survival in Newly Diagnosed Multiple Myeloma Patients Over Age 75 4Health News:Thalidomide Added to Standard Therapy Prolongs Overall Survival in Newly Diagnosed Multiple Myeloma Patients Over Age 75 5Health News:Thalidomide Added to Standard Therapy Prolongs Overall Survival in Newly Diagnosed Multiple Myeloma Patients Over Age 75 6Health News:Thalidomide Added to Standard Therapy Prolongs Overall Survival in Newly Diagnosed Multiple Myeloma Patients Over Age 75 7Health News:Dasatinib, Nilotinib show strong early results as frontline therapy for chronic myelogenous leukemia 2Health News:Dasatinib, Nilotinib show strong early results as frontline therapy for chronic myelogenous leukemia 3Health News:OHSU Cancer Institute research discovery opens new window to understanding chronic myeloid leukemia 2Health News:Heart Attacks Peak During the Holidays 2Health News:ZOLINZA (vorinostat) in combination with bortezomib demonstrated clinical activity 2Health News:ZOLINZA (vorinostat) in combination with bortezomib demonstrated clinical activity 3
... drainage from the ureteropelvic junction to the ... segment with no sideports prevents postoperative narrowing ... of the ureteral wall to the stent. ... one-time use. CAUTION: Periodic evaluation is advised; ...
... Whether you prefer silicone or ... Specialty Stents help promote healing after ... guards against anastomotic stricture, supports the ... the prevention of postoperative leakage. Following ...
... The Max-Blade™ Coagulating Resector is a device that ... This patented design was developed to provide the ... same high quality pathology chip, the approximate speed ... enjoyed with a standard loop but with ...
... Used for stone manipulation and removal in ... the basket to retain its shape following extreme ... stone capture by allowing the basket to open ... the stone. The tipless design reduces the likelihood ...
Medicine Products: